Gene Therapy in the Post-Gelsinger Era

Jona's Healthcare Law, Ethics, and Regulation 4 (4):104-110 (2002)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,923

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Gene replacement therapy in the CNS: A view from the retina.Gail M. Seigel - 1995 - Behavioral and Brain Sciences 18 (1):69-69.
Human gene therapy and slippery slope arguments.T. McGleenan - 1995 - Journal of Medical Ethics 21 (6):350-355.
Genetic Disorders and the Ethical Status of Germ-Line Gene Therapy.E. M. Berger & B. M. Gert - 1991 - Journal of Medicine and Philosophy 16 (6):667-683.
The Moral Significance of the Therapy-Enhancement Distinction in Human Genetics.David B. Resnik - 2000 - Cambridge Quarterly of Healthcare Ethics 9 (3):365-377.
Should we change the human genome?Torbjörn Tännsjö - 1993 - Theoretical Medicine and Bioethics 14 (3).
Human gene therapy and the slippery slope argument.Veikko Launis - 2002 - Medicine, Health Care and Philosophy 5 (2):169-179.
Complementarity between the Gene and Gene Therapy.Masayuki Obayashi - 1995 - Annals of the Japan Association for Philosophy of Science 8 (5):253-259.

Analytics

Added to PP
2014-02-02

Downloads
7 (#1,409,222)

6 months
2 (#1,255,269)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Gene Therapy Oversight: Lessons for Nanobiotechnology.Susan M. Wolf, Rishi Gupta & Peter Kohlhepp - 2009 - Journal of Law, Medicine and Ethics 37 (4):659-684.

Add more citations

References found in this work

No references found.

Add more references